PATENT CLAIM ANALYSIS

Application Number: 15743096
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "04400A"]

Abstract:
Methods and compounds useful to treat drug-induced diseases and conditions are provided. Methods of administering one or more MCJ-inhibiting compounds to decrease MCJ polypeptide activity in cells, tissues, and/or subjects as a treatment for a drug-induced disease or condition are provided.

Claim (Index 11):
The method of  claim 10 , wherein the siRNA molecule comprises a nucleic acid sequence set forth herein as SEQ ID NO:21.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 86.0
- Lexical Diversity: 1.32353
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14413927', '15551995', '12449265', '15753461', '12812811']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7430692198909566
- 35 USC 102 Novelty (BERT): 0.5634899862847739
- Combined Prediction Score: 0.7251112965303385
- Mean Citation Score: 330.115818
- Max Citation Score: 456.73486
- Similarity Product: 297.01256787118683

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test